Opportunity ID: 309655

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-19-029
Funding Opportunity Title: Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Environment
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 24
Assistance Listings: 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Oct 17, 2018
Last Updated Date: Jan 10, 2019
Original Closing Date for Applications: Jan 28, 2019
Current Closing Date for Applications: Feb 02, 2021
Archive Date: Mar 04, 2021
Estimated Total Program Funding: $1,200,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA) seeks to develop and nurture a national innovation ecosystem that builds upon biomedical research to develop technologies, products, and services that benefit society. Toward meeting this objective, the I-Corps program is being offered. The I-Corps at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. Under this FOA, participating NIH and CDC Institutes and Centers will continue providing administrative supplement awards to currently-funded SBIR and STTR Phase I grantees. The program is designed to provide three-member project teams with access to instruction and mentoring in order to accelerate the translation of technologies currently being developed with NIH and Centers for Disease Control and Prevention (CDC) SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact NIH or CDC Scientific/Research staff for more information about the program before applying.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-19-029.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Updated Expiration Date in accordance with the notice NOT-CA-19-017 Jan 10, 2019
Jan 10, 2019

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-19-029
Funding Opportunity Title: Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Environment
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 24
Assistance Listings: 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Oct 17, 2018
Last Updated Date: Jan 10, 2019
Original Closing Date for Applications: Jan 28, 2019
Current Closing Date for Applications: Feb 02, 2021
Archive Date: Mar 04, 2021
Estimated Total Program Funding: $1,200,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA) seeks to develop and nurture a national innovation ecosystem that builds upon biomedical research to develop technologies, products, and services that benefit society. Toward meeting this objective, the I-Corps program is being offered. The I-Corps at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. Under this FOA, participating NIH and CDC Institutes and Centers will continue providing administrative supplement awards to currently-funded SBIR and STTR Phase I grantees. The program is designed to provide three-member project teams with access to instruction and mentoring in order to accelerate the translation of technologies currently being developed with NIH and Centers for Disease Control and Prevention (CDC) SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact NIH or CDC Scientific/Research staff for more information about the program before applying.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-19-029.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-19-029
Funding Opportunity Title: Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Environment
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 24
Assistance Listings: 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 10, 2019
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 28, 2019
Archive Date: Mar 05, 2019
Estimated Total Program Funding: $1,200,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This funding opportunity announcement (FOA) seeks to develop and nurture a national innovation ecosystem that builds upon biomedical research to develop technologies, products, and services that benefit society. Toward meeting this objective, the I-Corps program is being offered. The I-Corps at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. Under this FOA, participating NIH and CDC Institutes and Centers will continue providing administrative supplement awards to currently-funded SBIR and STTR Phase I grantees. The program is designed to provide three-member project teams with access to instruction and mentoring in order to accelerate the translation of technologies currently being developed with NIH and Centers for Disease Control and Prevention (CDC) SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact NIH or CDC Scientific/Research staff for more information about the program before applying.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-19-029.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E-ADMINSUPP-RESEARCH Use for all R’s PKG00245600 Oct 19, 2018 Jun 25, 2020 View
FORMS-F-ADMINSUPP-RESEARCH Use for all R’s PKG00260664 Oct 19, 2018 Feb 02, 2021 View

Package 1

Mandatory forms

309655 RR_SF424_2_0-2.0.pdf

309655 PHS398_CoverPageSupplement_4_0-4.0.pdf

309655 RR_OtherProjectInfo_1_4-1.4.pdf

309655 PerformanceSite_2_0-2.0.pdf

309655 RR_KeyPersonExpanded_2_0-2.0.pdf

309655 PHS398_ResearchPlan_4_0-4.0.pdf

309655 RR_Budget10_1_4-1.4.pdf

Optional forms

309655 RR_SubawardBudget10_30_1_4-1.4.pdf

Package 2

Mandatory forms

309655 RR_SF424_2_0-2.0.pdf

309655 PHS398_CoverPageSupplement_5_0-5.0.pdf

309655 RR_OtherProjectInfo_1_4-1.4.pdf

309655 PerformanceSite_2_0-2.0.pdf

309655 RR_KeyPersonExpanded_2_0-2.0.pdf

309655 PHS398_ResearchPlan_4_0-4.0.pdf

309655 RR_Budget10_1_4-1.4.pdf

Optional forms

309655 RR_SubawardBudget10_30_1_4-1.4.pdf

309655 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

2025-07-09T08:49:02-05:00

Share This Post, Choose Your Platform!

About the Author: